HIV Citation List: September 2 - September 15, 2009
Pubmed citations:
1. Synthesis and In-vitro Activity of 4'-Modified Analogues of ddA as Potent Anti-HIV Agents. Hong JH, Oh CH. Arch Pharm (Weinheim). 2009 Sep 14. [Epub ahead of print] PMID: 19753563 [PubMed - as supplied by publisher]
2. Ellagitannins from Tuberaria lignosa as entry inhibitors of HIV. Bedoya LM, Abad MJ, Sánchez-Palomino S, Alcami J, Bermejo P. Phytomedicine. 2009 Sep 10. [Epub ahead of print] PMID: 19748255 [PubMed - as supplied by publisher]
3. Design, Synthesis, and Structure-Activity Relationship of a Novel Series of 2-Aryl 5-(4-Oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 Entry Inhibitors. Katritzky AR, Tala SR, Lu H, Vakulenko AV, Chen QY, Sivapackiam J, Pandya K, Jiang S, Debnath AK. J Med Chem. 2009 Sep 11. [Epub ahead of print] PMID: 19746983 [PubMed - as supplied by publisher]
4. Design, Synthesis, Protein-Ligand X-ray Structure, and Biological Evaluation of a Series of Novel Macrocyclic Human Immunodeficiency Virus-1 Protease Inhibitors to Combat Drug Resistance. Ghosh AK, Kulkarni S, Anderson DD, Hong L, Baldridge A, Wang YF, Chumanevich AA, Kovalevsky AY, Tojo Y, Masayuki A, Koh Y, Tang J, Weber IT, Mitsuya H. J Med Chem. 2009 Sep 11. [Epub ahead of print] PMID: 19746963 [PubMed - as supplied by publisher]
5. Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo. Kiem HP, Wu RA, Sun G, von Laer D, Rossi JJ, Trobridge GD. Gene Ther. 2009 Sep 10. [Epub ahead of print] PMID: 19741733 [PubMed - as supplied by publisher]
6. Apricitabine: A Nucleoside Reverse Transcriptase Inhibitor for HIV Infection (October) (CE). Gaffney MM, Belliveau PP, Spooner LM. Ann Pharmacother. 2009 Sep 8. [Epub ahead of print] PMID: 19737995 [PubMed - as supplied by publisher]
7. Identification and Characterization of a Highly Efficient Anti-HIV Pol Hammerhead Ribozyme. Müller-Kuller T, Capalbo G, Klebba C, Engels JW, Klein SA. Oligonucleotides. 2009 Sep 4. [Epub ahead of print] PMID: 19732019 [PubMed - as supplied by publisher]
8. 5-Azacytidine Can Induce Human Immunodeficiency Virus Type 1 Lethal Mutagenesis. Dapp MJ, Clouser CL, Patterson S, Mansky LM. J Virol. 2009 Sep 2. [Epub ahead of print] PMID: 19726509 [PubMed - as supplied by publisher]
9. The nucleoside analogue D-carba T blocks HIV-1 reverse transcription. Boyer PL, Vu BC, Ambrose Z, Julias JG, Warnecke S, Liao C, Meier C, Marquez VE, Hughes SH. J Med Chem. 2009 Sep 10;52(17):5356-64. PMID: 19678643 [PubMed - in process
10. Discovery of diarylpyridine derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Tian X, Qin B, Lu H, Lai W, Jiang S, Lee KH, Chen CH, Xie L. Bioorg Med Chem Lett. 2009 Sep 15;19(18):5482-5. Epub 2009 Jul 19. PMID: 19666220 [PubMed - in process]
ISI Web of Knowledge citations:
11. Human Immunodeficiency Virus Type 1 Nucleocapsid Inhibitors Impede trans Infopection in Cellular and Explant Models and Protect Nonhuman Primates from Infection. Wallace, GS; Cheng-Mayer, C; Schito, ML; Fletcher, P; Jenkins, LMM; Hayashi, R; Neurath, AR; Appella, E; Shattock, RJ. Journal of Virology, 2009; 83(18): 9175-9182.
12. Glucuronidation of the Antiretroviral Drug Efavirenz by UGT2B7 and an in Vitro Investigation of Drug-Drug Interaction with Zidovudine. Belanger, AS; Caron, P; Harvey, M; Zimmerman, PA; Mehlotra, RK; Guillemette, C. DRUG METABOLISM AND DISPOSITION, 2009; 37(9): 1793-1796.
13. Electronic transitions of neutral and anionic quinolinone HIV-1 integrase inhibitor: Joint theory/experiment investigation. Vandurm, P; Cauvin, C; Wouters, J; Perpete, EA; Jacquemin, D. CHEMICAL PHYSICS LETTERS, 2009; 478(4-6): 243-248.
14. Synthesis of (+/-)-4 '-ethynyl-5 ',5 '-difluoro-2 ',3 '-dehydro-3'-deoxy- carbocyclic thymidine: a difluoromethylidene analogue of promising anti-HIV agent Ed4T. Kumamoto, H; Haraguchi, K; Ida, M; Nakamura, KT; Kitagawa, Y; Hamasaki, T; Baba, M; Matsubayashi, SS; Tanaka, H. TETRAHEDRON, 2009; 65(36): 7630-7636.
15. Synthesis and Biological Evaluation of 6-Substituted Purinylcarbanucleosides with a Cyclopenta[b]thiophene Pseudosugar. Abeijon, P; Blanco, JM; Caamanoa, O; Fernandez, F; Garcia, MD; Garcia-Mera, X; Rodriguez-Borges, JE; Balzarini, J; De Clercq, E. SYNTHESIS-STUTTGART, 2009; 16: 2766-2772.
16. Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents. Birt, DF; Widrlechner, MP; Hammer, KDP; Hillwig, ML; Wei, JQ; Kraus, GA; Murphy, PA; Mccoy, JA; Wurtele, ES; Neighbors, JD; Wiemer, DE; Maury, WJ; Price, JP. PHARMACEUTICAL BIOLOGY, 2009; 47(8): 774-782.
17. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids. Tanaka, T; Nomura, W; Narumi, T; Esaka, A; Oishi, S; Ohashi, N; Itotani, K; Evans, BJ; Wang, ZX; Peiper, SC; Fujii, N; Tamamura, H. ORGANIC & BIOMOLECULAR CHEMISTRY, 2009; 18: 3805-3809.
18. SYNTHESIS OF 3 '-O-PHOSPHONOETHYL NUCLEOSIDES WITH AN ADENINE AND A THYMINE BASE MOIETY. Huang, QY; Herdewijn, P. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2009; 28(5-7): 337-351.
19. SYNTHESIS AND ANTIVIRAL ACTIVITY OF PURINE 2 ',3 '-DIDEOXY-2 ',3'-DIFLUORO-D-ARABINOFURANOSYL NUCLEOSIDES. Sivets, GG; Kalinichenko, EN; Mikhailopulo, IA; Detorio, MA; McBrayer, TR; Whitaker, T; Schinazi, RF. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2009; 28(5-7): 519-536.
20. CARBOCYCLIC THYMIDINE ANALOGUES FOR USE AS POTENTIAL THERAPEUTIC AGENTS. Seley-Radtke, KL; Sunkara, NK. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2009; 28(5-7): 633-641.
21. Composition and Antimicrobial Activity of the Leaf Essential oil of Litsea kostermansii from Taiwan. Ho, CL; Wang, EIC; Hsu, KP; Lee, PY; Su, YC. NATURAL PRODUCT COMMUNICATIONS, 2009; 4(8): 1123-1126.
22. Isoprenylated Chromone Derivatives from the Plant Endophytic Fungus Pestalotiopsis fici. Liu, L; Liu, SC; Niu, SB; Guo, LD; Chen, XL; Che, YS. JOURNAL OF NATURAL PRODUCTS, 2009; 72(8): 1482-1486.
23. Synthesis, antiviral activity, and stability of nucleoside analogs containing tricyclic bases. Amblard, F; Fromentin, E; Detorio, M; Obikhod, A; Rapp, KL; McBrayer, TR; Whitaker, T; Coats, SJ; Schinazi, RF. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009; 44(10): 3845-3851.
24. Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1 protease activity. Wei, Y; Ma, CM; Hattori, M. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009; 44(10): 4112-4120.